A Phase II Expansion Study of Vorinostat in Combination With Idarubicin and Cytarabine for Patients With Acute Myelogenous Leukemia (AML) With FLT3 Molecular Alterations
Title:
A Phase II Expansion Study of Vorinostat in Combination With Idarubicin and Cytarabine for Patients With Acute Myelogenous Leukemia (AML) With FLT3 Molecular Alterations
Author:
Takahashi, Koichi Jabbour, Elias Ravandi, Farhad Borthakur, Gautam Cortes, Jorge Kadia, Tapan O’Brien, Susan Thomas, Deborah Faderl, Stefan Bass, Joyce Wierda, William Daver, Naval Dinardo, Courtney Pierce, Sherry Brandt, Mark Kantarjian, Hagop Garcia-Manero, Guillermo